Home > Research > Publications & Outputs > Titin founder mutation is a common cause of myo...

Links

Text available via DOI:

View graph of relations

Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. / Pfeffer, Gerald; Barresi, Rita; Wilson, Ian J. et al.
In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 85, No. 3, 01.03.2014, p. 331-338.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Pfeffer, G, Barresi, R, Wilson, IJ, Hardy, SA, Griffin, H, Hudson, J, Elliott, HR, Ramesh, AV, Radunovic, A, Winer, JB, Vaidya, S, Raman, A, Busby, M, Farrugia, ME, Ming, A, Everett, C, Emsley, HCA, Horvath, R, Straub, V, Bushby, K, Lochmüller, H, Chinnery, PF & Sarkozy, A 2014, 'Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure', Journal of Neurology, Neurosurgery and Psychiatry, vol. 85, no. 3, pp. 331-338. https://doi.org/10.1136/jnnp-2012-304728

APA

Pfeffer, G., Barresi, R., Wilson, I. J., Hardy, S. A., Griffin, H., Hudson, J., Elliott, H. R., Ramesh, A. V., Radunovic, A., Winer, J. B., Vaidya, S., Raman, A., Busby, M., Farrugia, M. E., Ming, A., Everett, C., Emsley, H. C. A., Horvath, R., Straub, V., ... Sarkozy, A. (2014). Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. Journal of Neurology, Neurosurgery and Psychiatry, 85(3), 331-338. https://doi.org/10.1136/jnnp-2012-304728

Vancouver

Pfeffer G, Barresi R, Wilson IJ, Hardy SA, Griffin H, Hudson J et al. Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. Journal of Neurology, Neurosurgery and Psychiatry. 2014 Mar 1;85(3):331-338. Epub 2014 Feb 6. doi: 10.1136/jnnp-2012-304728

Author

Pfeffer, Gerald ; Barresi, Rita ; Wilson, Ian J. et al. / Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. In: Journal of Neurology, Neurosurgery and Psychiatry. 2014 ; Vol. 85, No. 3. pp. 331-338.

Bibtex

@article{f2b80d0bbf5e4d1f8f72e2a0e7e3ab6a,
title = "Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure",
abstract = "Objective Titin gene (TTN) mutations have been described in eight families with hereditary myopathy with early respiratory failure (HMERF). Some of the original patients had features resembling myofibrillar myopathy (MFM), arguing that TTN mutations could be a much more common cause of inherited muscle disease, especially in presence of early respiratory involvement. Methods We studied 127 undiagnosed patients with clinical presentation compatible with MFM. Sanger sequencing for the two previously described TTN mutations in HMERF (p.C30071R in the 119th fibronectin-3 (FN3) domain, and p.R32450W in the kinase domain) was performed in all patients. Patients with mutations had detailed review of their clinical records, muscle MRI findings and muscle pathology. Results We identified five new families with the p.C30071R mutation who were clinically similar to previously reported cases, and muscle pathology demonstrated diagnostic features of MFM. Two further families had novel variants in the 119th FN3 domain (p.P30091L and p.N30145K). No patients were identified with mutations at position p.32450. Conclusions Mutations in TTN are a cause of MFM, and titinopathy is more common than previously thought. The finding of the p.C30071R mutation in 3.9% of our study population is likely due to a British founder effect. The occurrence of novel FN3 domain variants, although still of uncertain pathogenicity, suggests that other mutations in this domain may cause MFM, and that the disease is likely to be globally distributed. We suggest that HMERF due to mutations in the TTN gene be nosologically classified as MFM-titinopathy.",
author = "Gerald Pfeffer and Rita Barresi and Wilson, {Ian J.} and Hardy, {Steven A.} and Helen Griffin and Judith Hudson and Elliott, {Hannah R.} and Ramesh, {Aravind V.} and Aleksandar Radunovic and Winer, {John B.} and Sujit Vaidya and Ashok Raman and Mark Busby and Farrugia, {Maria E.} and Alec Ming and Chris Everett and Emsley, {Hedley C. A.} and Rita Horvath and Volker Straub and Kate Bushby and Hanns Lochm{\"u}ller and Chinnery, {Patrick F.} and Anna Sarkozy",
year = "2014",
month = mar,
day = "1",
doi = "10.1136/jnnp-2012-304728",
language = "English",
volume = "85",
pages = "331--338",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "3",

}

RIS

TY - JOUR

T1 - Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure

AU - Pfeffer, Gerald

AU - Barresi, Rita

AU - Wilson, Ian J.

AU - Hardy, Steven A.

AU - Griffin, Helen

AU - Hudson, Judith

AU - Elliott, Hannah R.

AU - Ramesh, Aravind V.

AU - Radunovic, Aleksandar

AU - Winer, John B.

AU - Vaidya, Sujit

AU - Raman, Ashok

AU - Busby, Mark

AU - Farrugia, Maria E.

AU - Ming, Alec

AU - Everett, Chris

AU - Emsley, Hedley C. A.

AU - Horvath, Rita

AU - Straub, Volker

AU - Bushby, Kate

AU - Lochmüller, Hanns

AU - Chinnery, Patrick F.

AU - Sarkozy, Anna

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Objective Titin gene (TTN) mutations have been described in eight families with hereditary myopathy with early respiratory failure (HMERF). Some of the original patients had features resembling myofibrillar myopathy (MFM), arguing that TTN mutations could be a much more common cause of inherited muscle disease, especially in presence of early respiratory involvement. Methods We studied 127 undiagnosed patients with clinical presentation compatible with MFM. Sanger sequencing for the two previously described TTN mutations in HMERF (p.C30071R in the 119th fibronectin-3 (FN3) domain, and p.R32450W in the kinase domain) was performed in all patients. Patients with mutations had detailed review of their clinical records, muscle MRI findings and muscle pathology. Results We identified five new families with the p.C30071R mutation who were clinically similar to previously reported cases, and muscle pathology demonstrated diagnostic features of MFM. Two further families had novel variants in the 119th FN3 domain (p.P30091L and p.N30145K). No patients were identified with mutations at position p.32450. Conclusions Mutations in TTN are a cause of MFM, and titinopathy is more common than previously thought. The finding of the p.C30071R mutation in 3.9% of our study population is likely due to a British founder effect. The occurrence of novel FN3 domain variants, although still of uncertain pathogenicity, suggests that other mutations in this domain may cause MFM, and that the disease is likely to be globally distributed. We suggest that HMERF due to mutations in the TTN gene be nosologically classified as MFM-titinopathy.

AB - Objective Titin gene (TTN) mutations have been described in eight families with hereditary myopathy with early respiratory failure (HMERF). Some of the original patients had features resembling myofibrillar myopathy (MFM), arguing that TTN mutations could be a much more common cause of inherited muscle disease, especially in presence of early respiratory involvement. Methods We studied 127 undiagnosed patients with clinical presentation compatible with MFM. Sanger sequencing for the two previously described TTN mutations in HMERF (p.C30071R in the 119th fibronectin-3 (FN3) domain, and p.R32450W in the kinase domain) was performed in all patients. Patients with mutations had detailed review of their clinical records, muscle MRI findings and muscle pathology. Results We identified five new families with the p.C30071R mutation who were clinically similar to previously reported cases, and muscle pathology demonstrated diagnostic features of MFM. Two further families had novel variants in the 119th FN3 domain (p.P30091L and p.N30145K). No patients were identified with mutations at position p.32450. Conclusions Mutations in TTN are a cause of MFM, and titinopathy is more common than previously thought. The finding of the p.C30071R mutation in 3.9% of our study population is likely due to a British founder effect. The occurrence of novel FN3 domain variants, although still of uncertain pathogenicity, suggests that other mutations in this domain may cause MFM, and that the disease is likely to be globally distributed. We suggest that HMERF due to mutations in the TTN gene be nosologically classified as MFM-titinopathy.

U2 - 10.1136/jnnp-2012-304728

DO - 10.1136/jnnp-2012-304728

M3 - Journal article

C2 - 23486992

AN - SCOPUS:84896728430

VL - 85

SP - 331

EP - 338

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 3

ER -